跳至主要内容
临床试验/TCTR20190704002
TCTR20190704002招募中3 期

Endobiliary radiofrequency ablation in recurrence andunresectable cholangiocarcinoma

Khon Kaen University0 个研究点目标入组 72 人开始时间: 2019年7月4日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1. Age 18-75 years old.
  • 2. Unresectable or recurrent cholangiocarcinoma diagnosis by pathology or radiographic.
  • 3. Obstrucvtive jaundice (Total bilirubin > 3 mg/dl.)
  • 4. Aviable for ERCP and Percutaneous procedure.

排除标准

  • 1.Massive ascites.
  • 2.Uncorrectable coagulopathy.
  • 3.Presence of main portal vein thrombosis.
  • 4.Prior SEMS placement.
  • 5.Child-Pugh Score C cirrhosis.
  • 6.Pregnancy.
  • 7.Performance status ECOG ≥ 3 (confined to bed / chair > 50% waking hours).
  • 8.Presence of other malignancy.
  • 9.Life expectancy < 3months.
  • 10.Patients with cardiac pacemakers or other active implants.
  • 11.Comorbidities : Congestive heart failure, COPD, Sepsis
  • 12.Uncorrectable Thrombocytopenia (less than 100,000 /mm3), Uncorrectable Conagulopathy (INR > 1.5)

研究者

相似试验

Endobiliary radiofrequency ablation in recurrence... | 临床试验